Intralesional cidofovir for recurrent respiratory papillomatosis in children

Archives of Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 10, 1999, Pages 1143-1148

  Pransky, Seth M ^a   Magit, Anthony E ^b   Keams, Donald B ^c   Richard Kcing, D ^d   Duncan, Newton O ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d Texas Ear Nose and Throat Consult   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR;

ARTICLE; CARBON DIOXIDE LASER; CARCINOGENICITY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INFANT; INTRALESIONAL DRUG ADMINISTRATION; LARYNGOSCOPY; LARYNX PAPILLOMATOSIS; MALE; NEPHROTOXICITY; NEUTROPENIA; PRESCHOOL CHILD; PROTEINURIA; TUMOR RECURRENCE; WART VIRUS;

EID: 0032850760     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.125.10.1143     Document Type: Article

References (18)

1. Pransky SM, Kang DR. Tumors of the larynx, trachea, and bronchi. In: Bluestone CD, Stool SE, Kenna MA, eds. Pédiatrie Otolaryngotogy.Vo] 2. Philadelphia, Pa: WB Saunders Co; 1996:1402-1414.
2. Bauman NM, Smith RS. Recurrent respiratory papillomatosis. Py/afrC///iAtorf/; Am. 1996:43:13851401.
3. Derkay CS. Task force on recurrent respiratory papillomatosis: a preliminary report. Arch Oto/aryngol Head Neck Surg. 1995;121:1386-1391.
4. Kashima H, Leventhal B, Mounts P, Hruban RH. Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laiyngol. 1993;102:580-583.
5. Abramson A, Shikowitz M, Rullooly V, Steinberg B, Amelia C, Rothstein H. Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch Otolaryngol Head Neck Surg. 1992;118:25-29.
6. HealyGB,GelberRD,TrowbridgeAL,etal.Treatment of recurrent respiratory papillomatosis with human leukocyte interferon: results of a muiitcenter randomized clinical trial. NEnglJMed. 1988:319:401-407.
7. Leventhal B, Kashima H, Mounts P, et al. Longterm response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. NEnglJMed. 1991;325:613-617.
8. Avidano M, Singleton G. Adjuvant drug strategies in the treatment of recurrent respiratory papillomato-sis. OtolaryngolHeadNeckSurg. 1995;112:197-202.
9. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon aifa-2A . treatment of hemangionas of infancy. J Pediatr. 1998:132:527-530.
10. Recurrent Respiratory Papillomatosis Newsletter. Lawrenceville, NJ: RRP Foundation; Spring 1998.
11. Endres D, Bauman N, Burke D, Smith R. Acyclovir in the treatment of recurrent respiratory papillomatosis: a pilot study. Ann Otol RhinolLaryngot. 1994:103:301-305.
12. McGlennen R, Adams G, Lev/is C, Faras A, Ostrow R. Pilot trial of ribavirin for the treatment of laryngeal papiilomatosis. Head Neck. 1993;15:504-513.
13. De Clercq E. Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DMA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. Verh KAcad Geneesk Belg. 1996;58:19-47.
14. Ho H, Woods K, Bronson J, DeBoeck H, Martin J, Hitchcock M. Intracellular metabolism of the antiherpes agent (S)-1 -[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol Pharmacol. 1991; 41:197-202.
15. Lalezari J, Stagg R, Kuppermann B, et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1997;126:257-263.
16. Van Cutsem E, Snoeck R, Van Ranst M, et al. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)1 -(3-hydroxy-2-phosphonylmethoxypropyl) cytosine. JMed Virol. 1995:45:230-235.
17. Snoeck R, Wellens W, Desloovere C, Van Ranst M, De Clercq E, Feenstra L. Treatment of severe recurrent laryngeal papillomatosis by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (cidofovir). In: Programs and Abstracts of the Ninth International Conference on Antiviral Research; May 19-24,1996; Fukushima, Japan.
18. Snoeck R, Wleens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3hydroxy-2-phosphonylmethoxypropyl) cytosine]. J Virol. 1998:54:219-225.